In clinical practice, it is most often considered for patients dealing with gastritis-type irritation, reflux-type symptoms, inflammatory gut symptoms, medication-related GI irritation, intestinal permeability concerns, or gut lining support
At-home therapies include: Retinol creams
UnitedHealthcare does not cover compounded medications under any plan type
Finally, marketing and distribution
Eli Lilly Announces Positive Phase 3 Results for Retatrutide (TRIUMPH-2 & TRIUMPH-3) 23 July,2026 Eli Lilly and Company has announced positive topline results from two additional pivotal Phase 3 obesity trials, further strengthening the evidence for retatrutide, the investigational GIP/GLP-1/Glucagon triple receptor agonist
A higher prevalence is found in certain subgroups, for instance those living with multiple long-term conditions (MLTC) [3, 4]